This Cooperative Agreement award, valued at $4,726,553.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The University of Texas MD Anderson Cancer Center, located in Houston, Texas. The award will support a clinical consortium that includes a coordinating center and clinical research site. The funding will enable the center to conduct a range of biomedical research initiatives aimed at improving health outcomes for military service members, veterans, and the broader public. This may include projects across medical disciplines such as cancer research, neurological disorders, and emerging medical technologies. The award has a performance period from September 15, 2024 to September 14, 2026.
Generated 3/4/25, 6:34 AM